EAM
IPXL

Eagle Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Eagle Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-191,361
Closed -$8.97M – 678
2015
Q1 		$8.97M Sell
191,361
-118,501
-38% -$4.72M 0.05% 345
2014
Q4 		$9.82M Sell
309,862
-7,042
-2% -$206K 0.06% 333
2014
Q3 		$7.51M Sell
316,904
-33,036
-9% -$846K 0.04% 370
2014
Q2 		$10.5M Sell
349,940
-56,422
-14% -$1.52M 0.06% 332
2014
Q1 		$10.7M Buy
+406,362
New +$10.2M 0.06% 340

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Eagle Asset Management's IPXL Position: Q2 2015 in Review

Eagle Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2015, closing a stake of 191,361 shares — an estimated $8.97M sold.

Eagle Asset Management first reported a position in IPXL in Q1 2014 and held it in 5 quarters. The position peaked at $10.7M in Q1 2014. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

  • Eagle Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2015 after selling out during the quarter.
  • Eagle Asset Management sold 191,361 Impax Laboratories, Inc. shares in Q2 2015, an estimated $8.97M.
  • Eagle Asset Management first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 5 quarters.
  • Eagle Asset Management's Impax Laboratories, Inc. position peaked at $10.7M in Q1 2014.
  • 197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on Eagle Asset Management's 13F filing for Q2 2015, filed 15 Jul 2015.